NCT00959335View on ClinicalTrials.gov

Relative Bioavailability Study of Bicalutamide 50 mg Tablet and Casodex Following a 50 mg Dose in Healthy Subjects Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL

Enrollment

36

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

August 31, 2006

Study Completion Date

August 31, 2006

Conditions

Prostate CancerHirsutism

Interventions

DRUG

Bicalutamide 50 mg Film-Coated Tablets (Casodex) (Astrazeneca Pharmaceutical LP, USA)

DRUG

Bicalutamide 50 mg Film-Coated Tablets (Sandoz Inc., USA)

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sandoz

INDUSTRY

NCT00959335 - Relative Bioavailability Study of Bicalutamide 50 mg Tablet and Casodex Following a 50 mg Dose in Healthy Subjects Under Fasting Conditions | Biotech Hunter | Biotech Hunter